Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution.
Current microtubule-targeting agents (MTAs) remain amongst the most important antimitotic drugs used against a broad range of malignancies. By perturbing spindle assembly, MTAs activate the spindle assembly checkpoint (SAC), which induces mitotic arrest and subsequent apoptosis. However, besides tox...
Autor principal: | |
---|---|
Formato: | article |
Idioma: | eng |
Publicado em: |
2018
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/20.500.11816/2982 |
País: | Portugal |
Oai: | oai:repositorio.cespu.pt:20.500.11816/2982 |